Researchers from Switzerland have shown that patients with metabolic dysfunction-associated steatotic liver disease (MASLD) suffer poor sleep due to sleep fragmentation and wakefulness. Patients with ...

There are plenty of reasons why you might notice some redness, itching or inflammation on your face. In fact, everything from ...

A New 3D Bioprinted Model Offers a Novel Tool to Study Common Liver Disease, and Perhaps Find an Effective Treatment Jan. 23, 2024 — Metabolic dysfunction--associated steatohepatitis or MASH ...

MASLD (formerly known as non-alcoholic fatty liver disease) is the most common liver disorder: it affects 30 per cent of ...

AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as ...

Fatty liver disease is a growing health concern that often develops silently, showing no clear symptoms in its early stages.

Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH) are the most common causes of chronic liver disease in industrialized countries. NAFLD has ...

About one-third of US adults without diabetes who are eligible for weight loss treatment with GLP-1 receptor agonists and GLP-1/GIP receptor agonists meet exclusion criteria for clinical trials.

BHUBANESWAR: Three tribal women of Mandipanka village in Odisha’s Kandhamal district recently died after they consumed a ...

Nonalcoholic fatty liver disease (NAFLD) and its more severe form NASH are common liver diseases in industrialized countries. Diabetes, obesity, the metabolic syndrome and NAFLD all share common ...

A 77-year-old woman with a history of hepatitis C cirrhosis presents to the emergency department with 24 hours of progressive ...

Tune Therapeutics, an epigenome-editing company based in Durham and Seattle, will be the first to initiate a human clinical trial for an epigenetic therapy for a common infectious disease.